201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2017
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Mar 2017 Status changed from active, no longer recruiting to completed.
- 19 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 13 Jun 2016 Status changed from not yet recruiting to recruiting.